About Bridge to Life
Bridge to Life is a company based in Columbia (United States) founded in 2012 by Stevan F Schweighardt.. Bridge to Life has raised $57 million across 3 funding rounds from investors including Perceptive Advisors. Bridge to Life offers products and services including Belzer UW® Cold Storage Solution, Belzer MPS® UW Machine Perfusion Solution, and VitaSmart™ Hypothermic Oxygenated Machine Perfusion System. Bridge to Life operates in a competitive market with competitors including TransMedics, OrganOx, Brooks Automation, Paragonix Technologies and Hemanext, among others.
- Headquarter Columbia, United States
- Founders Stevan F Schweighardt
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bridge To Life Ltd.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$57 M (USD)
in 3 rounds
-
Latest Funding Round
$1 M (USD), Series A
Aug 07, 2024
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bridge to Life
Bridge to Life offers a comprehensive portfolio of products and services, including Belzer UW® Cold Storage Solution, Belzer MPS® UW Machine Perfusion Solution, and VitaSmart™ Hypothermic Oxygenated Machine Perfusion System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides cold storage for organs to maintain viability during transplantation.
Enables machine perfusion to assess and preserve donor organs effectively.
Supports hypothermic oxygenated perfusion for organ revitalization.
Unlock access to complete
Funding Insights of Bridge to Life
Bridge to Life has successfully raised a total of $57M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $1 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $1.0M
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2024 | Amount | Series A - Bridge to Life | Valuation |
investors |
|
| Aug, 2021 | Amount | Debt – Conventional - Bridge to Life | Valuation |
investors |
|
| Aug, 2021 | Amount | Series A - Bridge to Life | Valuation | Perceptive Advisors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Bridge to Life
Bridge to Life has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Perceptive Advisors. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health-tech companies are targeted for venture capital investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Bridge to Life
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Bridge to Life
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bridge To Life Comparisons
Competitors of Bridge to Life
Bridge to Life operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TransMedics, OrganOx, Brooks Automation, Paragonix Technologies and Hemanext, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of organ transplantation technology
|
|
| domain | founded_year | HQ Location |
Warm storage and transport systems for harvested organs are provided.
|
|
| domain | founded_year | HQ Location |
Vacuum robots for semiconductor wafer handling are developed.
|
|
| domain | founded_year | HQ Location |
Organ preservation and transport systems are developed for transplants.
|
|
| domain | founded_year | HQ Location |
Technologies for blood and product storage are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Bridge To Life
Frequently Asked Questions about Bridge to Life
When was Bridge to Life founded?
Bridge to Life was founded in 2012 and raised its 1st funding round 9 years after it was founded.
Where is Bridge to Life located?
Bridge to Life is headquartered in Columbia, United States.
Who is the current CEO of Bridge to Life?
Stevan F Schweighardt is the current CEO of Bridge to Life. They have also founded this company.
Is Bridge to Life a funded company?
Bridge to Life is a funded company, having raised a total of $57M across 3 funding rounds to date.
What does Bridge to Life do?
Bridge to Life was established in 2012 in Columbia, United States, as a provider in the medical sector focused on organ preservation. Cold storage solutions for transplant organs are offered, including Belzer UW-cold storage solution, Belzer MPS UW-machine perfusion solution, sodium chloride solution for sterile slush, and French-sized cannulas and tubing. Operations center on supplying these products to support transplant procedures across the region.
Who are the top competitors of Bridge to Life?
Bridge to Life's top competitors include TransMedics, OrganOx and Brooks Automation.
What products or services does Bridge to Life offer?
Bridge to Life offers Belzer UW® Cold Storage Solution, Belzer MPS® UW Machine Perfusion Solution, and VitaSmart™ Hypothermic Oxygenated Machine Perfusion System.
Who are Bridge to Life's investors?
Bridge to Life has 1 investor. Key investors include Perceptive Advisors.